Support PenkeSchroder Global Healthcare A Acc
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCAT.NASDAQ | Health Catalyst Inc | USA | Healthcare | Health Information Services | 2024-06-30 | 0.643 | 0.608 | 379.6k | $2.2m | $3.2m |
| |||||||||||||
| IMAB.NASDAQ | I-Mab | USA | Healthcare | Biotechnology | 2024-06-30 | 0.172 | 0.226 | 142.8k | $408.1k | $148.5k |
| |||||||||||||
| INBX.NASDAQ | Inhibrx Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.336 | 0.448 | 159k | $2.4m | $2.4m |
| |||||||||||||
| KZR.NASDAQ | Kezar Life Sciences Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.294 | 0.203 | 213.1k | $440.1k | $1.6m |
| |||||||||||||
| NYXH.NASDAQ | Nyxoah | USA | Healthcare | Medical Instruments & Supplies | 2024-06-30 | 0.623 | 0.305 | 233k | $791.5k | $2m |
| |||||||||||||
| REPL.NASDAQ | Replimune Group Inc | USA | Healthcare | Biotechnology | 2024-06-30 | 0.448 | 0.745 | 253.8k | $1.5m | $2.9m |
|
Trades
Adds
Report date: 2024-02-29
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| NYXH.NASDAQ | 4.6k | 2.0 | 36.3k | 4-18 | $8.60 | 115.0% |
Report date: 2024-01-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| NYXH.NASDAQ | 82.6k | 56.7 | 436.7k | 4-13 | $8.60 | 115.0% |
Report date: 2023-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| HCAT.NASDAQ | 153.9k | 68.2 | 1.2m | 7-10 | $8.66 | 31.2% |
Report date: 2023-04-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| NYXH.NASDAQ | 58.3k | 66.8 | 379.3k | 4-10 | $8.60 | 97.2% |
Report date: 2022-10-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| INBX.NASDAQ | 8.7k | 3.4 | 192.9k | 13-34 | $15.45 | 22.6% |
| REPL.NASDAQ | 56.9k | 28.9 | 1m | 15-22 | $11.69 | -22.4% |
Report date: 2022-07-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| INBX.NASDAQ | 109.1k | 73.7 | 1.5m | 8-22 | $15.45 | 101.4% |
Reduces
Report date: 2023-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| INBX.NASDAQ | -34.3k | -17.8 | -721.5k | 15-27 | $15.45 | 2.9% |
Report date: 2023-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| INBX.NASDAQ | -31.3k | -14.0 | -729.2k | 18-28 | $15.45 | -15.3% |
Report date: 2022-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| INBX.NASDAQ | -41.2k | -15.5 | -1.2m | 18-35 | $15.45 | -12.4% |
Comments
How you think about this?